The resultant α-LGR5scFv CAR T cells exhibited potent and specific killing of LGR5-overexpressing cells as well as LGR5+ pre-B ALL, CRC, and HCC tumour cell lines [22]. The gene discussed is LGR5; the disease is hepatocellular carcinoma.